← Eichor
Study identifier: NCT05562466 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Condition: Asthma  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 3
Planned participants200
Who can joinAll sexes, 6 Years to 11 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the superiority in terms of efficacy and evaluate the safety of QMF149 (indacaterol (acetate) / mometasone (furoate)) compared to budesonide in children from 6 to less than 12 years of age with asthma. * The study duration will be up to 37 weeks including an investigational treatment duration of 12 weeks and a comparator treatment duration of 12 weeks. * The visit frequency will be 3 weeks for screening, run-in and wash-out period, 6 weeks interval for visits during each treatment period, 30 days for safety follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  +41613241111  ·  novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (63)

Novartis Investigative SiteCABA, Buenos Aires, ArgentinaRecruiting
Novartis Investigative SiteCABA, Buenos Aires, ArgentinaRecruiting
Novartis Investigative SiteCABA, Buenos Aires, ArgentinaRecruiting
Novartis Investigative SiteMendoza, Mendoza Province, ArgentinaRecruiting
Novartis Investigative SiteRosario, Santa Fe Province, ArgentinaRecruiting
Novartis Investigative SiteRosario, Santa Fe Province, ArgentinaRecruiting
Novartis Investigative SiteGraz, AustriaWithdrawn
Novartis Investigative SiteSalzburg, AustriaWithdrawn
Novartis Investigative SiteSankt Pölten, AustriaWithdrawn
Novartis Investigative SiteSorocaba, São Paulo, BrazilRecruiting
Novartis Investigative SiteRousse, BulgariaRecruiting
Novartis Investigative SiteSevlievo, BulgariaRecruiting

+ 51 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05562466